Cargando…
Prevalence of SARS-CoV-2 specific neutralising antibodies in blood donors from the Lodi Red Zone in Lombardy, Italy, as at 06 April 2020
We evaluated SARS-CoV-2 RNA and neutralising antibodies in blood donors (BD) residing in the Lodi Red Zone, Italy. Of 390 BDs recruited after 20 February 2020 − when the first COVID-19 case in Lombardy was identified, 91 (23%) aged 19–70 years were antibody positive. Viral RNA was detected in an add...
| Autores principales: | , , , , , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
European Centre for Disease Prevention and Control (ECDC)
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7315724/ https://www.ncbi.nlm.nih.gov/pubmed/32583766 http://dx.doi.org/10.2807/1560-7917.ES.2020.25.24.2001031 |
| _version_ | 1783550315796103168 |
|---|---|
| author | Percivalle, Elena Cambiè, Giuseppe Cassaniti, Irene Nepita, Edoardo Vecchio Maserati, Roberta Ferrari, Alessandro Di Martino, Raffaella Isernia, Paola Mojoli, Francesco Bruno, Raffaele Tirani, Marcello Cereda, Danilo Nicora, Carlo Lombardo, Massimo Baldanti, Fausto |
| author_facet | Percivalle, Elena Cambiè, Giuseppe Cassaniti, Irene Nepita, Edoardo Vecchio Maserati, Roberta Ferrari, Alessandro Di Martino, Raffaella Isernia, Paola Mojoli, Francesco Bruno, Raffaele Tirani, Marcello Cereda, Danilo Nicora, Carlo Lombardo, Massimo Baldanti, Fausto |
| author_sort | Percivalle, Elena |
| collection | PubMed |
| description | We evaluated SARS-CoV-2 RNA and neutralising antibodies in blood donors (BD) residing in the Lodi Red Zone, Italy. Of 390 BDs recruited after 20 February 2020 − when the first COVID-19 case in Lombardy was identified, 91 (23%) aged 19–70 years were antibody positive. Viral RNA was detected in an additional 17 (4.3%) BDs, yielding ca 28% (108/390) with evidence of virus exposure. Five stored samples collected as early as 12 February were seropositive. |
| format | Online Article Text |
| id | pubmed-7315724 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2020 |
| publisher | European Centre for Disease Prevention and Control (ECDC) |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-73157242020-06-29 Prevalence of SARS-CoV-2 specific neutralising antibodies in blood donors from the Lodi Red Zone in Lombardy, Italy, as at 06 April 2020 Percivalle, Elena Cambiè, Giuseppe Cassaniti, Irene Nepita, Edoardo Vecchio Maserati, Roberta Ferrari, Alessandro Di Martino, Raffaella Isernia, Paola Mojoli, Francesco Bruno, Raffaele Tirani, Marcello Cereda, Danilo Nicora, Carlo Lombardo, Massimo Baldanti, Fausto Euro Surveill Rapid Communication We evaluated SARS-CoV-2 RNA and neutralising antibodies in blood donors (BD) residing in the Lodi Red Zone, Italy. Of 390 BDs recruited after 20 February 2020 − when the first COVID-19 case in Lombardy was identified, 91 (23%) aged 19–70 years were antibody positive. Viral RNA was detected in an additional 17 (4.3%) BDs, yielding ca 28% (108/390) with evidence of virus exposure. Five stored samples collected as early as 12 February were seropositive. European Centre for Disease Prevention and Control (ECDC) 2020-06-18 /pmc/articles/PMC7315724/ /pubmed/32583766 http://dx.doi.org/10.2807/1560-7917.ES.2020.25.24.2001031 Text en This article is copyright of the authors or their affiliated institutions, 2020. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution (CC BY 4.0) Licence. You may share and adapt the material, but must give appropriate credit to the source, provide a link to the licence, and indicate if changes were made. |
| spellingShingle | Rapid Communication Percivalle, Elena Cambiè, Giuseppe Cassaniti, Irene Nepita, Edoardo Vecchio Maserati, Roberta Ferrari, Alessandro Di Martino, Raffaella Isernia, Paola Mojoli, Francesco Bruno, Raffaele Tirani, Marcello Cereda, Danilo Nicora, Carlo Lombardo, Massimo Baldanti, Fausto Prevalence of SARS-CoV-2 specific neutralising antibodies in blood donors from the Lodi Red Zone in Lombardy, Italy, as at 06 April 2020 |
| title | Prevalence of SARS-CoV-2 specific neutralising antibodies in blood donors from the Lodi Red Zone in Lombardy, Italy, as at 06 April 2020 |
| title_full | Prevalence of SARS-CoV-2 specific neutralising antibodies in blood donors from the Lodi Red Zone in Lombardy, Italy, as at 06 April 2020 |
| title_fullStr | Prevalence of SARS-CoV-2 specific neutralising antibodies in blood donors from the Lodi Red Zone in Lombardy, Italy, as at 06 April 2020 |
| title_full_unstemmed | Prevalence of SARS-CoV-2 specific neutralising antibodies in blood donors from the Lodi Red Zone in Lombardy, Italy, as at 06 April 2020 |
| title_short | Prevalence of SARS-CoV-2 specific neutralising antibodies in blood donors from the Lodi Red Zone in Lombardy, Italy, as at 06 April 2020 |
| title_sort | prevalence of sars-cov-2 specific neutralising antibodies in blood donors from the lodi red zone in lombardy, italy, as at 06 april 2020 |
| topic | Rapid Communication |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7315724/ https://www.ncbi.nlm.nih.gov/pubmed/32583766 http://dx.doi.org/10.2807/1560-7917.ES.2020.25.24.2001031 |
| work_keys_str_mv | AT percivalleelena prevalenceofsarscov2specificneutralisingantibodiesinblooddonorsfromthelodiredzoneinlombardyitalyasat06april2020 AT cambiegiuseppe prevalenceofsarscov2specificneutralisingantibodiesinblooddonorsfromthelodiredzoneinlombardyitalyasat06april2020 AT cassanitiirene prevalenceofsarscov2specificneutralisingantibodiesinblooddonorsfromthelodiredzoneinlombardyitalyasat06april2020 AT nepitaedoardovecchio prevalenceofsarscov2specificneutralisingantibodiesinblooddonorsfromthelodiredzoneinlombardyitalyasat06april2020 AT maseratiroberta prevalenceofsarscov2specificneutralisingantibodiesinblooddonorsfromthelodiredzoneinlombardyitalyasat06april2020 AT ferrarialessandro prevalenceofsarscov2specificneutralisingantibodiesinblooddonorsfromthelodiredzoneinlombardyitalyasat06april2020 AT dimartinoraffaella prevalenceofsarscov2specificneutralisingantibodiesinblooddonorsfromthelodiredzoneinlombardyitalyasat06april2020 AT iserniapaola prevalenceofsarscov2specificneutralisingantibodiesinblooddonorsfromthelodiredzoneinlombardyitalyasat06april2020 AT mojolifrancesco prevalenceofsarscov2specificneutralisingantibodiesinblooddonorsfromthelodiredzoneinlombardyitalyasat06april2020 AT brunoraffaele prevalenceofsarscov2specificneutralisingantibodiesinblooddonorsfromthelodiredzoneinlombardyitalyasat06april2020 AT tiranimarcello prevalenceofsarscov2specificneutralisingantibodiesinblooddonorsfromthelodiredzoneinlombardyitalyasat06april2020 AT ceredadanilo prevalenceofsarscov2specificneutralisingantibodiesinblooddonorsfromthelodiredzoneinlombardyitalyasat06april2020 AT nicoracarlo prevalenceofsarscov2specificneutralisingantibodiesinblooddonorsfromthelodiredzoneinlombardyitalyasat06april2020 AT lombardomassimo prevalenceofsarscov2specificneutralisingantibodiesinblooddonorsfromthelodiredzoneinlombardyitalyasat06april2020 AT baldantifausto prevalenceofsarscov2specificneutralisingantibodiesinblooddonorsfromthelodiredzoneinlombardyitalyasat06april2020 |